Navigation Links
NAMSA Unveils New, Larger State-of-the-Art Analytical Chemistry Facility
Date:9/23/2009

Analytical Chemistry and Materials Characterization department doubles its capacity for medical device testing

Northwood, OH (PRWEB) September 23, 2009 -- NAMSA's Analytical Chemistry department is on the move. After months of planning, building and cleaning, the new, state-of-the-art Chemistry and Materials Characterization facility is now in use at NAMSA.

The new facility houses three different labs including a wet chemical lab, an instrumental services lab and a Volatile analysis lab. By doubling the capacity for Chemistry testing, NAMSA is better equipped to introduce new testing capabilities like Inductively Coupled Plasma Spectrometry (ICP) and Volatiles analysis USP 467 on-site.

"We believe this move positions us to provide enhanced turnaround time, better workflow to increase our testing workload and more efficiencies," said Joe Grappin, Chemistry Manager. "With the renovated and expanded space, we are able to add equipment and personnel to meet the increasing needs of materials analysis required by medical devices and combination products."

In addition to better turnaround times and increased speed to market, NAMSA's Research and Development team will also have increased capabilities to develop additional materials characterization assays. With all of these improvements for our clients, expanding the Chemistry lab was an easy decision for NAMSA's President, John Gorski, to make.

"We continue to invest in our people, facilities, equipment and clients because we believe that developing relationships and trust is the right thing to do; It has been a key to over 40 years of success," said Mr. Gorski. "Even during this economic downturn, NAMSA is committed to providing the best possible medical device testing services by growing our business and expanding our capabilities."

For more information about NAMSA's new Analytical Chemistry facility, contact Andrew Gottfried at agottfried(at)namsa.com.

About NAMSA
NAMSA, a leading Contract Research Organization, offers medical device testing and consulting services to medical device manufacturers worldwide. Specifically, we offer Analytical Chemistry and Materials Characterization, Efficacy testing, Biocompatibility testing, Clinical Trials and Sterility Assurance and Microbiology testing services. The U.S. laboratories are certified to ISO 13485 and accredited according to ISO 17025. Biomatech in France is accredited according to ISO 17025. For more detailed information about NAMSA's testing and consulting services, please visit http://www.namsa.com.

Contact Information
For further information about NAMSA or this news release, contact:

Andrew Gottfried
Product Manager
P 419.662.4458
F 419.662.4802
www.namsa.com

###

Read the full story at http://www.prweb.com/releases/2009/09/prweb2924754.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. NAMSA Deploys TrackWise Software as its Quality Management System
2. Seattle Personal Injury Attorney Corrie Yackulic Opens Law Firm, Unveils New Website
3. Lumension Unveils Enhanced Compliance and IT Risk Management Solution that Enables Organizations to Continuously Monitor Compliance and IT Risk Posture while Reducing the Overall Cost of Compliance
4. APS Healthcare Unveils New Corporate Headquarters in White Plains, Bringing 200 New Jobs, With Help From New York and Westchester
5. Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients
6. RBC Life Sciences Unveils the ClearPay System - the Industrys First Balancing Compensation Plan That Pays Quickly and Abundantly
7. FertilityTies, Social Network for the Fertility-Focused Unveils New Site Design, Unique Features to Help Patients Find Fertility Doctors & More
8. Myoderm Unveils Commercial Drug Procurement, Management & Distribution Service
9. N2Care Unveils Backyard Smart MEDcottage
10. 3D3 Solutions Unveils FlexScan3D Version 2.5 3D Scanner; New Features Speed Up the 3D Scanning Process
11. AVMA Unveils Improved Online Press Room to Help Journalists
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NAMSA Unveils New, Larger State-of-the-Art Analytical Chemistry Facility
(Date:8/18/2017)... (PRWEB) , ... ... ... For Immediate ... Polling Shows Young Women Seek Sex and Relationship Advice from ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces the ... healthy lifestyles and highlighting the importance of proactive eye and ear health. The ... the latest innovations in hearing aid technology. , In this issue, the ...
(Date:8/18/2017)... WV (PRWEB) , ... August 18, 2017 , ... ... financial consulting services and asset protection assistance to communities in North-Central West Virginia, ... provide critical services to at-risk boys in the area. , The Chestnut Mountain ...
(Date:8/18/2017)... ... August 18, 2017 , ... Goss & Associates ... residential and commercial clients in the greater Houston region, is helping locally recognized ... the fight against cancer. , Founded by Tony and Amber Bender after losing ...
(Date:8/18/2017)... ... ... Overseer at The House of Yahweh in Abilene, Texas, has released a new publication this ... of the Savior whom the world calls “Mother Mary”. Yisrayl says when compared to what ... historical woman. , “The world bows, kisses the feet of, cries out to and ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Aug. 15, 2017   Mostyn Law and Gulf Coast ... Houston, Texas . The Mostyn Law family has ... years. That is why Mostyn Law is partnering with ... to show its appreciation. Blood supplies are running low. ... short of hospital needs in August. That is why the blood ...
(Date:8/15/2017)... 15, 2017  AOTI Inc. announced today that its fully owned ... recently opened a New York City Office in Yonkers, ... unique Topical Wound Oxygen (TWO 2 ) homecare therapy. This new ... for Health Care (ACHC) under the company,s DMEPOS accreditation for Home/Durable ... Advanced ...
(Date:8/8/2017)... AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: ... immunology, today reports its financial results for the second ... achievements during the second quarter 2017 and to date: ... multiple clinical development programs for the Company,s lead project, ... 3 pivotal study with BL-8040 as novel stem cell ...
Breaking Medicine Technology: